Durata Therapeutics, Inc.
(NASDAQ : DRTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
1.73%60.511.4%$1553.01m
JNJJohnson & Johnson
0.92%140.850.7%$876.73m
PFEPfizer Inc.
0.93%38.390.9%$781.41m
MRKMerck & Co., Inc.
0.30%89.020.7%$682.63m
ABBVAbbVie, Inc.
0.90%87.502.3%$666.61m
LLYEli Lilly & Co.
0.44%120.301.1%$351.37m
NVSNovartis AG
0.84%92.410.2%$143.29m
AZNAstraZeneca Plc
0.19%47.711.2%$139.89m
RETAReata Pharmaceuticals, Inc.
-0.52%198.513.5%$134.73m
GSKGlaxoSmithKline Plc
0.61%45.490.2%$128.03m
KRTXKaruna Therapeutics, Inc.
5.99%69.360.0%$103.79m
NVONovo Nordisk A/S
-0.73%56.660.1%$88.95m
SNYSanofi
0.01%46.090.2%$76.74m
ALLKAllakos, Inc.
-6.16%115.480.0%$59.21m
CNSTConstellation Pharmaceuticals, Inc.
-0.07%42.620.0%$43.89m

Company Profile

Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL.